About Business
AbbVie Inc. is a public pharmaceutical company based in America and was founded on 10 April 2012. Currently, the CEO and chairman of the company is Richard A. Gonzalez, and Robert Michael is the COO and President on 1 June 2024. The headquarters of AbbVie is located at 1 North Waukegan Road, North Chicago, Illinois, and it offers its products in 170+ countries around the world. The main products of the company are Imbruvica, Kaletra, Humira, Mavyret/Maviret, Zinbryta, Skyrizi, Norvir, and Venclexta. As of 2024, AbbVie has 50,000 employees and is ranked sixth position on the list of largest biomedical companies in terms of revenue. In addition, it held the 74th position in Forbes Global 2000 in 2023 and 89th place in 2024. Humira (adalimumab) alone generated $14 billion of revenue in 2023 for the company. The name AbbVie is the combination of its parent company, Abbott, and the Latin word Vie, which means life. AbbVie is working on developing the drug for Parkinson's disease and is waiting for approval from the Food and Drug Administration.